Evidence map›Paper›PMID 20547768›Full record

ArticleThe Journal of biological chemistry2010

Vitamin A metabolite, all-trans-retinoic acid, mediates alternative splicing of protein kinase C deltaVIII (PKCdeltaVIII) isoform via splicing factor SC35.

Hercules Apostolatos, André Apostolatos, Timothy Vickers, James E Watson, Shijie Song, Fernando Vale, Denise R Cooper, Juan Sanchez-Ramos, Niketa A Patel

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Splicing factor SRSF2-centric gene regulation.International journal of biological sciences · 2021
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Cardiac actions of protein kinase C isoforms.Physiology (Bethesda, Md.) · 2012
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Hercules ApostolatosJames A Haley Veterans Hospital, Tampa, Florida 33612, USA.
André Apostolatos
Timothy Vickers
James E Watson
Shijie Song
Fernando Vale
Denise R Cooper
Juan Sanchez-Ramos
Niketa A Patel
University of South Florida · USJames A. Haley Veterans' Hospital · USIonis Pharmaceuticals (United States) · US

Funding

Mechanisms for treating ischemic wounds with human adipocyte derived stem cell exosomesI01BX003689 · VA · JAMES A. HALEY VA MEDICAL CENTER · PI COOPER, DENISE RATZLAFF · 2017 to 2022
–
PHS HHS 54393
6 · The paper itself

Abstract

Vitamin A metabolite, all-trans-retinoic acid (RA), induces cell growth, differentiation, and apoptosis and has an emerging role in gene regulation and alternative splicing events. Protein kinase Cdelta (PKCdelta), a serine/threonine kinase, has a role in cell proliferation, differentiation, and apoptosis. We reported an alternatively spliced variant of human PKCdelta, PKCdeltaVIII that functions as a pro-survival protein (1). RA regulates the splicing and expression of PKCdeltaVIII via utilization of a downstream 5' splice site of exon 10 on PKCdelta pre-mRNA. Here, we further elucidate the molecular mechanisms involved in RA regulation of alternative splicing of PKCdeltaVIII mRNA. Overexpression and knockdown of the splicing factor SC35 (i.e. SRp30b) indicated that it is involved in PKCdeltaVIII alternative splicing. To identify the cis-elements involved in 5' splice site selection we cloned a minigene, which included PKCdelta exon 10 and its flanking introns in the pSPL3 splicing vector. Alternative 5' splice site utilization in the minigene was promoted by RA. Further, co-transfection of SC35 with PKCdelta minigene promoted selection of 5' splice site II. Mutation of the SC35 binding site in the PKCdelta minigene abolished RA-mediated utilization of 5' splice splice II. RNA binding assays demonstrated that the enhancer element downstream of PKCdelta exon 10 is a SC35 cis-element. We conclude that SC35 is pivotal in RA-mediated PKCdelta pre-mRNA alternative splicing. This study demonstrates how a nutrient, vitamin A, via its metabolite RA, regulates alternative splicing and thereby gene expression of the pro-survival protein PKCdeltaVIII.

Indexed as

Alternative SplicingApoptosisBinding SitesCells, CulturedCell SurvivalGene Expression RegulationHumansNeuronsNuclear ProteinsProtein Kinase C-deltaRibonucleoproteinsSerine-Arginine Splicing FactorsTretinoinVitamin ANuclear ProteinsPRKCD protein, humanProtein Kinase C-deltaRibonucleoproteinsSerine-Arginine Splicing FactorsSRSF2 protein, humanTretinoinVitamin A

Identifiers

PMID20547768
PMCPMC2923993
OpenAlexW2024854479

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.